Watch as Dr. Gooddata makes the switch from paper data collection to mEDU, a CFR Part 11 compliant software with CloudEDC™ that is FREE for investigator initiated trials.
mCore is Medrio's all Phase eClinical suite which includes Cloud EDC™. It is well suited for Phase II, III, IV, in Pharma, Diagnostics, Medical Device, and Animal Health studies.
m1 is Medrio's eclinical suite for Phase I including Cloud EDC™ and all the features you need to make your Phase I trial run smoothly.
In this video, customers from across the clinical research industry reflect on their experience with Medrio’s software. Highlights include the software’s user-friendly functionality, quick study build, and affordability.
Thinking about electronic informed consent? In this short video, industry expert Sandra "Sam" Sather discusses the three key benefits of adopting eConsent in your clinical trial.
When it comes to user experience design, we’re thinking about our patients and the different symptoms that they might be suffering. The UX design aims to ensure that the needs of both the patients and the clinical trials are covered with the functional and visual design of the eCOA solutions.
Adopting a patient-centric focus in your trial is known to lead to more engaged patients and higher quality, more accurate clinical data. In this short, 3-minute video we explore how electronic Clinical Outcomes Assessment (eCOA) technology is revolutionizing the clinical trial experience for patients and sites - helping sponsors to easily overcome the toughest challenges of paper-based data collection.
The success of your clinical trial is contingent on the quality of the data you collect. In this short video, members of CRF Health's Data Management and Quality Assurance teams discuss the regulatory needs of clinical data and specific ways in which eCOA promotes the capture of higher quality data compared to traditional paper instruments.
We develop next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N.
The evaluation of the compatibility between scores from an electronic version of a paper-based questionnaire, better known as equivalence testing, is usually taken as a requirement for ensuring that data from electronic versions of patient reported outcomes does not vary from that captured on paper. This webinar discusses the results of a recently published meta-analysis which examined all published equivalence tests from 2007 to 2013. This webinar discusses equivalence testing, how the current meta-analysis run, and what the results mean in context of the field of eCOA.
|
|
|
|
|
|
|
|
|